Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Ocular Therapeutix (OCUL) Revenue: 2012-2024

Historic Revenue for Ocular Therapeutix (OCUL) over the last 13 years, with Dec 2024 value amounting to $63.7 million.

  • Ocular Therapeutix's Revenue fell 5.71% to $14.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.8 million, marking a year-over-year decrease of 9.21%. This contributed to the annual value of $63.7 million for FY2024, which is 9.03% up from last year.
  • According to the latest figures from FY2024, Ocular Therapeutix's Revenue is $63.7 million, which was up 9.03% from $58.4 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Revenue registered a high of $63.7 million during FY2024, and its lowest value of $17.4 million during FY2020.
  • Over the past 3 years, Ocular Therapeutix's median Revenue value was $58.4 million (recorded in 2023), while the average stood at $57.9 million.
  • Data for Ocular Therapeutix's Revenue shows a peak YoY skyrocketed of 311.71% (in 2020) over the last 5 years.
  • Ocular Therapeutix's Revenue (Yearly) stood at $17.4 million in 2020, then skyrocketed by 150.08% to $43.5 million in 2021, then rose by 18.32% to $51.5 million in 2022, then rose by 13.49% to $58.4 million in 2023, then rose by 9.03% to $63.7 million in 2024.